D
Daniel Lighezan
Publications - 12
Citations - 540
Daniel Lighezan is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 4 publications receiving 460 citations.
Papers
More filters
Journal ArticleDOI
Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach,Manfredi Rizzo,Peter P. Toth,Michel Farnier,Michael H. Davidson,Khalid Al-Rasadi,Wilbert S. Aronow,Vasilis G. Athyros,Dragan M. Djuric,Marat V. Ezhov,Robert S. Greenfield,G. Kees Hovingh,Karam Kostner,Corina Serban,Daniel Lighezan,Zlatko Fras,Patrick M. Moriarty,Paul Muntner,Assen Goudev,Richard Ceska,Stephen J. Nicholls,Marlena Broncel,Dragana Nikolic,Daniel Pella,Raman Puri,Jacek Rysz,Nathan D. Wong,Laszlo Bajnok,Steven R. Jones,Kausik K. Ray,Dimitri P. Mikhailidis +30 more
TL;DR: The aim of this position paper was to suggest a unified definition of statin intolerance, and to complement the recent EAS statement on SAMS, where the pathophysiology, diagnosis and the management were comprehensively presented.
Journal ArticleDOI
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach,Manfredi Rizzo,Peter P. Toth,Michel Farnier,Michael H. Davidson,Khalid Al-Rasadi,Wilbert S. Aronow,Vasilis G. Athyros,Dragan M. Djuric,Marat V. Ezhov,Robert S. Greenfield,G. Kees Hovingh,Karam Kostner,Corina Serban,Daniel Lighezan,Zlatko Fras,Patrick M. Moriarty,Paul Muntner,Assen Goudev,Richard Ceska,Stephen J. Nicholls,Marlena Broncel,Dragana Nikolic,Daniel Pella,Raman Puri,Jacek Rysz,Nathan D. Wong,Laszlo Bajnok,Steven R. Jones,Kausik K. Ray,Dimitri P. Mikhailidis +30 more
TL;DR: The aim of this position paper was to suggest a unified definition of statin intolerance, and to complement the recent EAS statement on SAMS, where the pathophysiology, diagnosis and the management were comprehensively presented.
Journal ArticleDOI
COVID-19 Independent Risk Factors for Unfavorable Disease Progression: A Cross-Sectional Study from Romania
Ruxandra Laza,Voichita Lazureanu,Virgil Musta,Narcisa Nicolescu,Corina Vernic,Anca Tudor,Roxana Critu,Laura Vilceanu,Roxana Paczeyka,Valerica Bica Profir,Adelina Raluca Marinescu,Alexandra Mocanu,Talida Georgiana Cut,Daniel Lighezan,Luminiţa Bădiţoiu +14 more
TL;DR: Older age, the number of disease duration days before hospital admission, BMI, and renal pathology are independent risk factors for mortality in COVID-19 and can help clinicians to identify patients with poor prognosis and who are at high risk for mortality at an early stage.
Journal ArticleDOI
Dyspepsia and Gut Microbiota in Female Patients with Postcholecystectomy Syndrome
Doina Georgescu,Alexandru Caraba,Ioana Inta,Ana Lascu,E F Huţ,Simona Dragan,Oana Elena Ancusa,Ioana Suceava,Daniel Lighezan +8 more
TL;DR: PCS in female patients was associated with older age, sedentary lifestyle, specific dietary habits, history of complicated gallstone disease, diabetes mellitus/impaired glucose tolerance and irritable bowel syndrome, as well as gut microbiota particularities.
Uncontrolled hypertension in primary care
Elena Ardeleanu,Daniel Lighezan,Rodica Lighezan,Alexandra Deleanu,Marinela Popovici,Raul B. Suciu,Patricia Nicola,Victor Babes +7 more
TL;DR: Compared with controlled hypertension, uncontrolled hypertensive patients were more often older, presented more severe and long hypertension evolution, organ damage and cardiovascular complications.